Simplex Trading’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-5,600
| Closed | -$550K | – | 8972 |
|
|
2025
Q2 | $550K | Buy |
5,600
+2,700
| +93% | +$255K | ﹤0.01% | 3405 |
|
|
2025
Q1 | $268K | Sell |
2,900
-2,400
| -45% | -$221K | ﹤0.01% | 4027 |
|
|
2024
Q4 | $481K | Buy |
5,300
+3,400
| +179% | +$312K | ﹤0.01% | 3580 |
|
|
2024
Q3 | $183K | Buy |
1,900
+200
| +12% | +$19.5K | ﹤0.01% | 4597 |
|
|
2024
Q2 | $156K | Sell |
1,700
-800
| -32% | -$74.2K | ﹤0.01% | 4898 |
|
|
2024
Q1 | $230K | Sell |
2,500
-400
| -14% | -$37.5K | ﹤0.01% | 4687 |
|
|
2023
Q4 | $275K | Buy |
2,900
+2,000
| +222% | +$187K | ﹤0.01% | 4320 |
|
|
2023
Q3 | $84K | Sell |
900
-1,900
| -68% | -$176K | ﹤0.01% | 5262 |
|
|
2023
Q2 | $256K | Buy |
2,800
+1,100
| +65% | +$90.2K | ﹤0.01% | 4024 |
|
|
2023
Q1 | $125K | Buy |
1,700
+400
| +31% | +$34.6K | ﹤0.01% | 4900 |
|
|
2022
Q4 | $108K | Sell |
1,300
-10,000
| -88% | -$902K | ﹤0.01% | 4969 |
|
|
2022
Q3 | $1.09M | Sell |
11,300
-13,400
| -54% | -$1.6M | ﹤0.01% | 2551 |
|
|
2022
Q2 | $2.6M | Buy |
24,700
+21,100
| +586% | +$2.7M | ﹤0.01% | 1626 |
|
|
2022
Q1 | $620K | Buy |
3,600
+2,000
| +125% | +$299K | ﹤0.01% | 3560 |
|
|
2021
Q4 | $259K | Buy |
1,600
+1,400
| +700% | +$225K | ﹤0.01% | 4788 |
|
|
2021
Q3 | $52K | Hold |
200
| – | – | ﹤0.01% | 7461 |
|
|
2021
Q2 | $48K | Buy |
200
+197
| +6,567% | +$51.7K | ﹤0.01% | 7674 |
|
|
2021
Q1 | $79K | Sell |
3
-5
| -63% | -$1.41K | ﹤0.01% | 6058 |
|
|
2020
Q4 | $234K | Sell |
8
-167
| -95% | -$42.8K | ﹤0.01% | 4393 |
|
|
2020
Q3 | $4.14M | Hold |
175
| – | – | 0.01% | 994 |
|
|
2020
Q2 | $3.47M | Sell |
175
-30
| -15% | -$5.59K | 0.01% | 1085 |
|
|
2020
Q1 | $3.76M | Buy |
205
+197
| +2,463% | +$35K | 0.01% | 854 |
|
|
2019
Q4 | $133K | Sell |
8
-216
| -96% | -$32.1K | ﹤0.01% | 4201 |
|
|
2019
Q3 | $2.93M | Sell |
224
-7
| -3% | -$911 | 0.01% | 1040 |
|
|
2019
Q2 | $2.8M | Buy |
231
+163
| +240% | +$19.3K | 0.01% | 1048 |
|
|
2019
Q1 | $838K | Sell |
68
-4
| -6% | -$502 | ﹤0.01% | 2149 |
|
|
2018
Q4 | $843K | Sell |
72
-63
| -47% | -$7.42K | ﹤0.01% | 1770 |
|
|
2018
Q3 | $1.69M | Buy |
135
+134
| +13,400% | +$14.8K | 0.01% | 1393 |
|
|
2018
Q2 | $8K | Buy |
+1
| New | +$73 | ﹤0.01% | 6448 |
|
|
2018
Q1 | – | Sell |
-7
| Closed | -$1K | – | 6047 |
|
|
2017
Q4 | $1K | Hold |
7
| – | – | ﹤0.01% | 5407 |
|
|
2017
Q3 | $4K | Sell |
7
-57
| -89% | -$3.01K | ﹤0.01% | 4517 |
|
|
2017
Q2 | $10K | Buy |
+64
| New | +$3.73K | ﹤0.01% | 3944 |
|
|
2017
Q1 | – | Sell |
-16
| Closed | -$1K | – | 6084 |
|
|
2016
Q4 | $1K | Buy |
16
+8
| +100% | +$340 | ﹤0.01% | 5292 |
|
|
2016
Q3 | $2K | Sell |
8
-4
| -33% | -$200 | ﹤0.01% | 4867 |
|
|
2016
Q2 | $1K | Sell |
12
-9
| -43% | -$454 | ﹤0.01% | 5182 |
|
|
2016
Q1 | $7K | Sell |
21
-16
| -43% | -$617 | ﹤0.01% | 3771 |
|
|
2015
Q4 | $29K | Buy |
37
+1
| +3% | +$40 | ﹤0.01% | 2369 |
|
|
2015
Q3 | $40K | Buy |
36
+19
| +112% | +$801 | ﹤0.01% | 2155 |
|
|
2015
Q2 | $41K | Sell |
17
-14
| -45% | -$436 | ﹤0.01% | 1834 |
|
|
2015
Q1 | $21K | Buy |
+31
| New | +$875 | ﹤0.01% | 2288 |
|
Other funds holding AMED
IA
MCI
HNB
Simplex Trading's AMED Position: Q1 2025 in Review
Simplex Trading sold out of Amedisys (AMED) in Q1 2025, closing a stake of 9,350 shares — an estimated $862K sold.
Simplex Trading first reported a position in AMED in Q4 2014 and held it in 22 quarters. The position peaked at $3.02M in Q1 2022. 304 funds tracked by Wall St. Rank hold AMED as of Q1 2025.
- Simplex Trading reported no remaining Amedisys position as of Q1 2025 after selling out during the quarter.
- Simplex Trading sold 9,350 Amedisys shares in Q1 2025, an estimated $862K.
- Simplex Trading first reported a position in Amedisys in Q4 2014 and held it in 22 quarters.
- Simplex Trading's Amedisys position peaked at $3.02M in Q1 2022.
- 304 funds tracked by Wall St. Rank held Amedisys as of Q1 2025.
Based on Simplex Trading's 13F filing for Q1 2025, filed 12 May 2025.